Rare diseases
Investigational molecules
Locations
353 conditions with trials, the busiest first
844 trials across Europe, recruiting first
Long-Term Safety Study of ST-920 Gene Therapy for Patients with Fabry Disease
GermanyStudy on NTLA-2002 for Treating Hereditary Angioedema in Patients: Evaluating the Effects of Ziclumeran and Lonvoguran
FranceStudy of local treatment options for large metastases in patients with BRAF V600 mutated melanoma receiving Encorafenib and Binimetinib combination therapy
GermanyStudy on the Effectiveness of Clindamycin and Tretinoin Gel for Treating Acne in Patients
GreeceStudy on Dupilumab for Itch Relief in Adults with Lichen Simplex Chronicus (Neurodermatitis)
BelgiumStudy of Deucrictibant Extended-Release Tablets for Prevention of Hereditary Angioedema Attacks in Adults and Adolescents
BulgariaStudy Comparing CT-P55 and Secukinumab for Moderate to Severe Plaque Psoriasis Patients
PolandStudy on the Effectiveness of Allo-APZ2-CVU for Patients with Long-Term, Non-Healing Venous Leg Ulcers
AustriaStudy on the Use of Indocyanine Green and Technetium (99mTc) Nanocolloid for Sentinel Node Biopsy in Patients with Melanoma, Oral Cancer, or Penile Cancer
The NetherlandsStudy on the Effectiveness of Enfortumab Vedotin and Pembrolizumab for Patients with Advanced Melanoma
SpainStudy on the Effectiveness and Safety of Brensocatib for Adults with Moderate to Severe Hidradenitis Suppurativa
BulgariaStudy on the Effectiveness of IC0624 for Patients with Mild to Moderate Hidradenitis Suppurativa
GermanyThe therapies tested most often in Skin and subcutaneous tissue disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
